Search Results 1571-1580 of 19100 for Enzyme
Participation eligibility · Absolute neutrophil count ≥ 1.5 × 109/L · Ratio between the concentrations of the enzymes aspartate transaminase (AST) and alanine ...
Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy work in different ways to ...
Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving GDC-0449 together with erlotinib ...
... enzyme [ACE] inhibitors, and angiotensin II receptor blockers). Subjects with a history or presence of any systemic condition (e.g., heart failure or kidney ...
Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow ...
Medicines called angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) can help control blood pressure. These medicines ...
Tivantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether cetuximab is more ...
... enzymes. NOTE: The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial ...
Amyloidosis frequently affects the heart, kidneys, liver, spleen, nervous system and digestive tract. It is often overlooked because it may cause no symptoms at ...
Medicines called angiotensin-converting enzyme (ACE) inhibitors and angiotensin 2 receptor blockers (ARBs) are used to treat high blood pressure. Blood ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.